Big Biotech Growing Faster than Big Pharma Says Burrill Report
April 19, 2013
April 19, 2013 | A new report from Burrill, says that Big Biotech has outpaced Big Pharma in terms of growth of sales, income, investment in R&D and market cap during the past three years. Big Biotech companies used in the analysis included Amgen, Gilead Sciences, Biogen Idec, Celgene, Alexion Pharmaceuticals, Regeneron Pharmaceuticals, Shire, Vertex Pharmaceuticals, BioMarin Pharmaceutical, Elan and Onyx. PharmaTimes